Therefore, the objective of this study was to determine the effect of infliximab (IFX), a TNF-α antagonist, on osteocytic RANKL and sclerostin expression in STZ-induced type 1 diabetes rats with periodontitis. The gene discussed is TNF; the disease is periodontitis.